Email Updates

You are here

Home»Media

AVAC in the News

  • Why We’re Still Optimistic Even in Disappointment About an HIV Vaccine

    An HIV vaccine remains what South Africa and the world needs to prevent new HIV infections. This is in addition to a range of other HIV prevention tools that are available and in the pipeline. However, one of the HIV vaccine research studies, Uhambo (HVTN 702), has been stopped early because it was determined by an independent review body that it did not show a possibility to prevent HIV. This, for a moment, came as disappointing news; however, as South Africans we realise the search for a safe and effective HIV vaccine has to continue.

    February 6, 2020
    HIV Vaccine
    Daily Maverick

  • Another HIV Vaccine Fails a Trial, Disappointing Researchers

    In another setback in the long quest to prevent HIV infection, a trial in South Africa has been shut down because an experimental vaccine was not working, federal health officials announced on Monday.

    February 4, 2020
    HIV Vaccine
    New York Times

  • Promising HIV Vaccine Proves Ineffective

    A vaccine trial against HIV in South Africa has proven ineffective, prompting the National Institute of Allergy and Infectious Diseases to stop it. Scientists were cautiously optimistic about the trial, which involved 5,407 HIV-negative volunteers at 14 sites across South Africa.

    February 4, 2020
    HIV Vaccine
    Devex

  • Large Scale HIV Vaccine Study Failed, but There’s Hope

    One of the biggest HIV vaccine trials in the world, the HVTN 702 study, was stopped late on Monday because the vaccine had not been proven effective in preventing HIV. This is according to the United States National Institute of Allergy and Infectious Diseases (NIAID), who are one of the funders of the clinical trial.

    February 4, 2020
    HIV Vaccine
    Health-E News

  • Another HIV Vaccine Strategy Fails in Large-scale Study

    The HIV vaccine that had moved furthest along in human testing does not work, and the $104 million trial in South Africa evaluating it has been stopped early.

    February 3, 2020
    HIV Vaccine
    Science

  • Trial of Promising HIV Vaccine Halted After Failing to Show Benefit

    A clinical trial testing a promising HIV vaccine in more than 5,000 people in South Africa has been halted because it failed to show a benefit, US health officials said on Monday.

    February 3, 2020
    HIV Vaccine
    Reuters

  • ‘Incredibly Disappointing’: Fred Hutch, Feds End HIV Vaccine Trial After Data Shows No Benefit

    In another blow to the decades-long quest for an HIV vaccine, researchers are pulling the plug on the largest ongoing clinical trial after a review in January found the experimental injections provided no protection from the virus that causes AIDS.

    February 3, 2020
    HIV Vaccine
    Seattle Times

  • HIV Vaccine Trial Stopped After Jab Found Ineffective

    Suth Africa will halt one of the largest and most advanced HIV vaccine trials ever to be undertaken in the country ahead of schedule after the jab was found to be safe but not effective at protecting against HIV infection.

    February 3, 2020
    HIV Vaccine
    Bhekisisa

  • The Global Gag Rule Is Still Hurting Women and Girls

    The US Government knows how to do smart, effective HIV programming globally — but for the past three years, it has been getting in its own way. That’s because the US President’s Emergency Plan for AIDS Relief (PEPFAR), the largest government commitment to global HIV, was placed at risk when President Trump reintroduced the so-called global gag rule, applying it for the first time to PEPFAR.

    January 23, 2020
    General
    INKSTICK

  • In Search of Comprehensive HIV Prevention

    A nightclub at Balaka Town is bulging with sex workers and their clients in search of pleasure and money. Within the compound, faint lights from florescent tubes are casting small beams onto an entrance into an adjoining room.

    January 13, 2020
    PrEP
    The Times Malawi

Pages